Dow Jones Newswires: Roche backs 2022 outlook as profit climbs, boosted by diagnostics sales

This post was originally published on this site

Roche Holding AG said Thursday that profit for the first half of the year increased as sales grew, mainly driven by the diagnostics division.

The Swiss pharmaceutical company CH:ROG CH:RO posted a net profit of 8.53 billion Swiss francs ($8.78 billion) compared with CHF7.80 billion a year earlier on sales that rose to CHF32.29 billion from CHF30.71 billion.

Analysts…